Catecholamine-Induced β2-Adrenergic Receptor Activation Mediates Desensitization of Gastric Cancer Cells to Trastuzumab by Upregulating MUC4 ExpressionMing Shi, Ning Guo, Zhengyan Yang et al.|The Journal of Immunology|2013Cited by 73
Sirolimus Can Increase the Disappearance Rate of Cardiac Rhabdomyomas Associated with Tuberous Sclerosis: A Prospective Cohort and Self-Controlled Case Series StudyXiao-Qiao Chen, Li‐Ping Zou, Yangyang Wang et al.|The Journal of Pediatrics|2021Cited by 24
Very early recurrence predicts long-term outcome in patients after atrial fibrillation catheter ablation: a prospective studyYangjing Xue, Kangting Ji, Lianming Liao et al.|BMC Cardiovascular Disorders|2017Cited by 22
Sirolimus treatment for tuberous sclerosis complex prior to epilepsy: Evidence from a registry-based real-world studyYan-Wen Shen, Li‐Ping Zou, Yang‐Yang Wang et al.|Seizure|2022Cited by 22
Long-term safety and influence on growth in patients receiving sirolimus: a pooled analysisYang‐Yang Wang, Yufen Li, Li‐Ping Zou et al.|Orphanet Journal of Rare Diseases|2024Cited by 11